Literature DB >> 21254341

Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels.

Elizabeth Coss1, Kymberly D S Watt, Rachel Pedersen, Ross Dierkhising, Julie K Heimbach, Michael R Charlton.   

Abstract

Cardiovascular complications are major causes of morbidity and mortality after liver transplantation. Identifying candidates at highest risk of postoperative complications is a cornerstone of optimizing outcomes and utility. Using traditional cardiac risk factors in addition to C-reactive protein (CRP) levels, troponin levels, and echocardiographic parameters before transplantation, we sought to define cardiac risk so that we could predict cardiovascular events after transplantation. From December 1998 to December 2001, 230 adult patients who underwent liver transplantation with a median follow-up of 8.2 years were studied. The risk factors for cardiac disease were as follows: male gender with a mean age of approximately 50 years (57%), smoking history (60%), diabetes (23%), hypertension (19%), elevated troponin (25%), elevated CRP (25%), and preexisting cardiac disease (16%). Fifty-nine cardiac events occurred over 8.2 years. Risk factors (univariate analysis) for first cardiac events included age in decades [hazard ratio (HR) = 1.31, P = 0.047], diabetes (HR = 2.20, P = 0.004), prior cardiovascular disease (HR = 4.77, P < 0.0001), a troponin I level > 0.07 ng/mL (HR = 2.00, P = 0.023), left ventricular hypertrophy (HR = 2.06, P = 0.047), stress wall abnormalities (HR = 2.25, P = 0.018), and ischemia on stress imaging (HR = 2.89, P = 0.015). Multivariate analysis confirmed age, diabetes, a troponin I level > 0.07, and prior cardiac disease as independent risk factors for posttransplant cardiac events. In conclusion, pretransplant elevated troponin levels, diabetes, and a history of cardiovascular disease, alone or in combination, are strongly associated with the occurrence of posttransplant cardiovascular events.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254341     DOI: 10.1002/lt.22140

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  21 in total

1.  Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation.

Authors:  Mario Reis Alvares-da-Silva; Claudia Pinto Marques Souza de Oliveira; José Tadeu Stefano; Hermes V Barbeiro; Denise Barbeiro; Francisco G Soriano; Alberto Queiroz Farias; Flair José Carrilho; Luiz Augusto Carneiro D'Albuquerque
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: The CAR-OLT score.

Authors:  Lisa B VanWagner; Hongyan Ning; Maureen Whitsett; Josh Levitsky; Sarah Uttal; John T Wilkins; Michael M Abecassis; Daniela P Ladner; Anton I Skaro; Donald M Lloyd-Jones
Journal:  Hepatology       Date:  2017-11-06       Impact factor: 17.425

Review 3.  [Anesthesia with liver failure].

Authors:  Eva-Lotte Camboni-Schellenberg; Barbara Sinner
Journal:  Anaesthesist       Date:  2016-01       Impact factor: 1.041

4.  Redefining Cirrhotic Cardiomyopathy for the Modern Era.

Authors:  Manhal Izzy; Lisa B VanWagner; Grace Lin; Mario Altieri; James Y Findlay; Jae K Oh; Kymberly D Watt; Samuel S Lee
Journal:  Hepatology       Date:  2019-10-11       Impact factor: 17.425

5.  High early cardiovascular mortality after liver transplantation.

Authors:  Lisa B VanWagner; Brittany Lapin; Josh Levitsky; John T Wilkins; Michael M Abecassis; Anton I Skaro; Donald M Lloyd-Jones
Journal:  Liver Transpl       Date:  2014-10-24       Impact factor: 5.799

Review 6.  Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes After Liver Transplantation: A Systematic Review.

Authors:  Monica A Konerman; Danielle Fritze; Richard L Weinberg; Christopher J Sonnenday; Pratima Sharma
Journal:  Transplantation       Date:  2017-07       Impact factor: 4.939

7.  Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample.

Authors:  L B VanWagner; M Serper; R Kang; J Levitsky; S Hohmann; M Abecassis; A Skaro; D M Lloyd-Jones
Journal:  Am J Transplant       Date:  2016-03-29       Impact factor: 8.086

8.  Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events.

Authors:  Kymberly D Watt; Chun Fan; Terry Therneau; Julie K Heimbach; Eric C Seaberg; Michael R Charlton
Journal:  Liver Transpl       Date:  2014-05-26       Impact factor: 5.799

9.  Stroke volume response to liver graft reperfusion stress in cirrhotic patients.

Authors:  Bibiana Escobar; Pilar Taurá; Graciela Martínez-Palli; Constatino Fondevila; Jaume Balust; Joan Beltrán; Javier Fernández; Juan Carlos García-Pagán; Juan Carlos García-Valdecasas
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

10.  The predictors of post-transplant coronary events among liver transplant recipients.

Authors:  Mohammad U Malik; Stuart D Russell; Aliaksei Pustavoitau; Matthews Chacko; Arif M Cosar; Carol B Thompson; Panagiotis Trilianos; Nabil N Dagher; Andrew M Cameron; Ahmet Gurakar
Journal:  Hepatol Int       Date:  2016-06-16       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.